Cargando…

Clinical characteristics in new psychoactive substance users: A single center study

New psychoactive substances (NPS) are emerging illegal substances or synthetic drugs that pose public health threats worldwide. This study was aimed at reporting the clinical characteristics of NPS and classical illicit substances used by patients who presented to the emergency room. We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yu-Jang, Chen, Tse-Hao, Liao, Wei-Hsiang, Chang, Kuo-Song, Lai, Yen-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289540/
https://www.ncbi.nlm.nih.gov/pubmed/37352073
http://dx.doi.org/10.1097/MD.0000000000034084
_version_ 1785062302265901056
author Su, Yu-Jang
Chen, Tse-Hao
Liao, Wei-Hsiang
Chang, Kuo-Song
Lai, Yen-Chun
author_facet Su, Yu-Jang
Chen, Tse-Hao
Liao, Wei-Hsiang
Chang, Kuo-Song
Lai, Yen-Chun
author_sort Su, Yu-Jang
collection PubMed
description New psychoactive substances (NPS) are emerging illegal substances or synthetic drugs that pose public health threats worldwide. This study was aimed at reporting the clinical characteristics of NPS and classical illicit substances used by patients who presented to the emergency room. We conducted a retrospective cohort study on patients with suspected illicit substance use who visited the emergency department (ED) with the suspicion of illicit substance use. We divided the patients into 4 groups based on the NPS testing results: NPS positive, NPS negative, NPS combined with classical illicit drugs (INPS), and subjects with negative testing results. The majority of patients in all groups were male. The NPS users were significantly younger than those with negative results on toxic testing (26.4 vs 37.5, P = .005 < 0.05). The heart rate of NPS users was significantly faster than that of the group with negative results of toxic testing (111.1 vs 93.5 beats per minute, P = .046). The heartbeats of INPS group were also significantly faster than those with a negative result in toxicology screen (119.6 vs 93.5 beats per minute, P = .024). Those who used classical illicit drugs combined with NPS had significantly higher palpitation than those with negative results of toxic testing (27.3% vs 3.1%, P = .017). Patients who were highly suspicious of NPS use were younger, had tachycardia, felt palpitations, and had fair oxygen saturation compared to patients who were negative for urine toxicity screening.
format Online
Article
Text
id pubmed-10289540
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102895402023-06-24 Clinical characteristics in new psychoactive substance users: A single center study Su, Yu-Jang Chen, Tse-Hao Liao, Wei-Hsiang Chang, Kuo-Song Lai, Yen-Chun Medicine (Baltimore) 7200 New psychoactive substances (NPS) are emerging illegal substances or synthetic drugs that pose public health threats worldwide. This study was aimed at reporting the clinical characteristics of NPS and classical illicit substances used by patients who presented to the emergency room. We conducted a retrospective cohort study on patients with suspected illicit substance use who visited the emergency department (ED) with the suspicion of illicit substance use. We divided the patients into 4 groups based on the NPS testing results: NPS positive, NPS negative, NPS combined with classical illicit drugs (INPS), and subjects with negative testing results. The majority of patients in all groups were male. The NPS users were significantly younger than those with negative results on toxic testing (26.4 vs 37.5, P = .005 < 0.05). The heart rate of NPS users was significantly faster than that of the group with negative results of toxic testing (111.1 vs 93.5 beats per minute, P = .046). The heartbeats of INPS group were also significantly faster than those with a negative result in toxicology screen (119.6 vs 93.5 beats per minute, P = .024). Those who used classical illicit drugs combined with NPS had significantly higher palpitation than those with negative results of toxic testing (27.3% vs 3.1%, P = .017). Patients who were highly suspicious of NPS use were younger, had tachycardia, felt palpitations, and had fair oxygen saturation compared to patients who were negative for urine toxicity screening. Lippincott Williams & Wilkins 2023-06-23 /pmc/articles/PMC10289540/ /pubmed/37352073 http://dx.doi.org/10.1097/MD.0000000000034084 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 7200
Su, Yu-Jang
Chen, Tse-Hao
Liao, Wei-Hsiang
Chang, Kuo-Song
Lai, Yen-Chun
Clinical characteristics in new psychoactive substance users: A single center study
title Clinical characteristics in new psychoactive substance users: A single center study
title_full Clinical characteristics in new psychoactive substance users: A single center study
title_fullStr Clinical characteristics in new psychoactive substance users: A single center study
title_full_unstemmed Clinical characteristics in new psychoactive substance users: A single center study
title_short Clinical characteristics in new psychoactive substance users: A single center study
title_sort clinical characteristics in new psychoactive substance users: a single center study
topic 7200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289540/
https://www.ncbi.nlm.nih.gov/pubmed/37352073
http://dx.doi.org/10.1097/MD.0000000000034084
work_keys_str_mv AT suyujang clinicalcharacteristicsinnewpsychoactivesubstanceusersasinglecenterstudy
AT chentsehao clinicalcharacteristicsinnewpsychoactivesubstanceusersasinglecenterstudy
AT liaoweihsiang clinicalcharacteristicsinnewpsychoactivesubstanceusersasinglecenterstudy
AT changkuosong clinicalcharacteristicsinnewpsychoactivesubstanceusersasinglecenterstudy
AT laiyenchun clinicalcharacteristicsinnewpsychoactivesubstanceusersasinglecenterstudy